Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study) - DocWire News
Submitted by Anonymous (not verified) on Tue, 06/29/2021 - 06:00
